
Terlizen Injection 1mg/ml
Marketer
Zencus Pharma
Salt Composition
Terlipressin (1mg/ml)
Overview Terlizen Injection 1mg/ml
Octreotide acetate injection (1mg/ml) is indicated for managing hemorrhage from esophageal varices (enlarged veins in the esophagus). Its mechanism involves vasoconstriction, reducing blood flow to affected veins. Administration is strictly by a qualified healthcare provider; self-injection is prohibited. Dosage and frequency are determined solely by your physician, and treatment is reserved for patients with severe, life-threatening esophageal bleeding. Potential side effects include cephalalgia, bradycardia, hypertension, peripheral vasoconstriction, and peripheral ischemia, or hypotension. Report persistent or worsening side effects to your doctor immediately. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and list all concurrent medications. This medication is contraindicated in pediatric and adolescent populations.
Uses of Terlizen Injection 1mg/ml
Life-threatening esophageal vein hemorrhage
Major Benefits of Terlizen Injection 1mg/ml:
Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.
Common Side effects of Terlizen Injection 1mg/ml:
- Headache
- Slow heart rate
- Abdominal cramp
- Diarrhea
- High blood pressure
- Peripheral ischemia
- Vasoconstriction of the extremities
How to use Terlizen Injection 1mg/ml:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Terlizen Injection 1mg/ml works:
Terlizen Injection (1mg/ml) constricts blood vessel walls in affected veins, reducing blood flow to control or halt hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Terlizen Injection 1mg/ml is not established as safe. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Terlizen Injection 1mg/ml during gestation is strongly contraindicated. Pregnant individuals should consult their physician; research in both animal models and human pregnancies reveals substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on Terlizen Injection 1mg/ml use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Terlizen Injection 1mg/ml on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Terlizen Injection 1mg/ml to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Terlizen Injection 1mg/ml use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Terlizen Injection 1mg/ml :
Omit a missed dose of Terlizen Injection 1mg/ml and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Terlizen Injection 1mg/ml
| Label | Value |
|---|---|
| Chemical Type | Synthetic vasopressin |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Synthetic vasopressin |
